Accession Number: | 0001209191-22-044013 |
Date: | 2022-07-29 |
Issuer: | AMNEAL PHARMACEUTICALS, INC. (AMRX) |
Original Submission Date: |
AUTOR DEBORAH M.
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER, NJ 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2022-07-29 | deemed execution date | A | 54,949 (a) | class a common stock 54,949 | $0.00 | 54,949 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's class a common stock. |
f2 | restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant. |